Cargando…
High expression of erythropoietin-producing hepatoma cell line-B2 (EphB2) predicts the efficiency of the Qingyihuaji formula treatment in pancreatic cancer CFPAC-1 cells through the EphrinB1-EphB2 pathway
Our previous study demonstrated that inhibition of erythropoietin-producing hepatoma cell line-B2 (EphB2) expression resulted in the promotion of cancer growth, with EphB2 acting as a tumor suppressor in pancreatic cancer. Qingyihuaji formula (QYHJ), a traditional Chinese medicine, acts as an indepe...
Autores principales: | HUA, YONG-QIANG, CHEN, ZHEN, MENG, ZHI-QIANG, CHEN, HAO, SHEN, JIAN-GANG, WANG, KUN, PENG, WANG, SHEN, YE-HUA, LIU, LU-MING |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4063575/ https://www.ncbi.nlm.nih.gov/pubmed/24959213 http://dx.doi.org/10.3892/ol.2014.2134 |
Ejemplares similares
-
EphB4/EphrinB2 therapeutics in Rhabdomyosarcoma
por: Randolph, Matthew E., et al.
Publicado: (2017) -
EphrinB2–EphB4 Signaling in Neurooncological Disease
por: Piffko, Andras, et al.
Publicado: (2022) -
EphB/ephrinB Signaling in Cell Adhesion and Migration
por: Park, Inji, et al.
Publicado: (2015) -
Coexpression of EphB4 and ephrinB2 in tumour advancement of ovarian cancers
por: Alam, S M, et al.
Publicado: (2008) -
EphrinB2/EphB4 signaling regulates non‐sprouting angiogenesis by VEGF
por: Groppa, Elena, et al.
Publicado: (2018)